ArticleJournal of neuroendovascular therapy2025
Predictors of Futile Recanalization after Mechanical Thrombectomy for Embolism-Related Large Vessel Occlusion in the Anterior Circulation.
Article in Journal of neuroendovascular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- DSA-NRP: No-Reflow Prediction From Angiographic Perfusion Dynamics in Stroke EVT.IEEE transactions on medical imaging · 2026Article
- Preoperative volume of mildly delayed time predicts 24-hour complete reperfusion after successful mechanical thrombectomy.BMC neurology · 2026Article
- Predictors of Futile Recanalization after Mechanical Thrombectomy for Middle Cerebral Artery M2 Occlusion.Journal of neuroendovascular therapy · 2026Article
- Refractory Thrombectomy: Incidence and Related Factors in a Third-Level Stroke Treatment Center.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Futile recanalization (FR)-a poor functional outcome despite successful reperfusion after mechanical thrombectomy (MT)-remains a significant issue in acute ischemic stroke owing to large vessel occlusion. This study aimed to identify predictors of FR, focusing on CT perfusion (CTP) parameters using our institutional retrospective data. Methods: Patients who underwent MT at our institution between April 2015 and February 2023 were retrospectively reviewed. FR was defined as a 90-day modified Rankin Scale (mRS) score of 3-6 despite successful reperfusion (modified thrombolysis in cerebral infarction ≥2b). Patients with internal carotid artery (ICA) or M1 segment of the middle cerebral artery occlusion, pre-stroke mRS 0-2, stroke etiology classified as cardioembolic or embolic stroke of undetermined source, and available CTP were included. The ischemic core was defined as cerebral blood volume (CBV) <1.0 mL/100 g on CTP, and the Alberta Stroke Program Early CT Score (ASPECTS) was also evaluated. Clinical, imaging, and procedural variables were compared between the FR group and those with a favorable outcome (mRS 0-2) after successful reperfusion. Multivariable logistic regression was performed, including imaging markers and variables with p <0.1 in univariate analyses as covariates. Receiver-operating characteristic (ROC) analyses determined thresholds for ASPECTS and CBV-defined core volume, followed by sensitivity analyses. Results: A total of 531 patients underwent MT during the study period, of whom 136 met the inclusion criteria (mean age 78 ± 11 years, 70 women, 46 ICA occlusions, median ASPECTS 9; interquartile range, 7-10). FR was observed in 69 patients (50.8%). Compared with the favorable outcome group, the FR group had significantly older age, higher baseline NIHSS scores, higher prevalence of diabetes mellitus, lower ASPECTS, larger CBV-defined core volumes, and a greater total number of device passes. Multivariable logistic regression identified older age, higher NIHSS, diabetes mellitus, and a greater total number of device passes as consistently independent predictors of FR. ROC analysis identified CBV-defined core volume ≥28.5 mL as an independent predictor of FR (area under the curve [AUC] 0.62, p = 0.013; adjusted odds ratio [aOR] 3.09, 95% confidence interval [CI] 1.23-8.28; p = 0.02); this association remained significant at ≥30 mL (aOR 2.82, 95% CI 1.14-7.33; p = 0.02) but not at ≥40 mL. ASPECTS ≤8 was also associated with FR (AUC 0.64, p = 0.002; aOR 2.92, 95% CI 1.20-7.44; p = 0.02). Conclusion: Older age, baseline stroke severity, diabetes mellitus, and multiple device passes were major predictors of FR. Among imaging markers, a CBV-defined core volume of approximately 30 mL emerged as a clinically relevant threshold associated with increased FR risk. These findings suggest that integrating clinical, procedural, and imaging factors may help optimize patient selection, although validation in larger, multicenter studies is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.